The adaptive growth of the uterus is a critical event that involves changes in cellular phenotypes throughout pregnancy. In early pregnancy, uterine growth is due to hyperplasia of uterine smooth muscle cells (SMCs) within the myometrium; however, the major component of myometrial growth occurs after mid-gestation. This study sought to test the hypothesis that increase in myometrial growth seen during late pregnancy is due to SMC hypertrophy caused by mechanical stretch of uterine tissue by a growing fetus(es) by providing direct measurements of individual SMC size. We employed a stereological approach to calculate the average cell volumes of uterine myocytes through diameter measurements using the Stereoinvestigator statistical software. Uterine tissues were collected from nonpregnant Wistar rats, as well as from gravid and nongravid horns of unilaterally pregnant animals on gestational days (d) 8 (early gestation), 14 (mid-gestation), 19 (late gestation), 22 (term), and 4 days post partum. Anti-caveolin-1 immunostaining was used to clearly delineate SMC boundaries. The stereological analysis revealed that the dramatic increase in myometrial growth seen during late gestation (d19-22) is due to a threefold increase in the size of uterine myocytes. A significant increase in SMC volumes was detected in the gravid uterine horn as compared with the corresponding empty horn of unilateral term pregnant animals (day 22, mean cell volume 1114 vs 361 mm 3 , P!0.05), indicating the effect of uterine occupancy. The restriction of the hypertrophy to cells within the gravid horn suggests that it may be a response to the biological mechanical stretch of uterine walls by the growing fetus(es) and placenta(s). Stretch induces myometrial hypertrophy 253 www.reproduction-online.org Reproduction (2010) 139 247-253
Introduction
Uterine smooth muscle undergoes dramatic physiological adaptations during the course of pregnancy. We described earlier two distinct phases of myometrial growth from early to late pregnancy: 1) myocyte hyperplasia associated with an increase in anti-apoptotic proteins in the first half of gestation ('proliferative' phase) and 2) myometrial hypertrophy associated with the increase in smooth muscle cell (SMC) size ('synthetic' phase) in the second half of gestation (Shynlova et al. 2006) . Cellular hypertrophy is characterized by an increase in cellular protein and is associated with increased thickness of uterine muscle layers, as well as with significant changes in mass and composition of extracellular matrix, the tension-bearing components of the uterus (Harkness & Harkness 1954 , Gabella 1990 , Shynlova et al. 2004 .
Despite the remarkable nature of uterine growth during pregnancy, there is little information as to the mechanisms that initiate and regulate these two growth phases. We have recently discovered that activation of the IGF1/PI3K/MTOR signaling pathway in uterine myocytes by estrogen is responsible for the induction of myometrial hyperplasia during the proliferative phase of gestation (Jaffer et al. 2009 ). However, few potential mechanisms regulating myometrial hypertrophy have been proposed in the literature. It was reported that ovarian hormones, estrogen and progesterone, were able to induce myometrial hypertrophy (Martin et al. 1973 , Koseki & Fujimoto 1974 . Several groups in the past have also suggested that in addition to endocrine factors, the enlarging fetus might induce uterine growth by stretching the uterine wall (Csapo et al. 1965 . The experimental uterine distension by saline fluid-filled balloon was applied into nonpregnant (NP) uterine horns to mimic the mechanical stretch induced during pregnancy ). This study demonstrated an increased uterine growth due to a combination of both hypertrophy and hyperplasia ). However, the NP model does not account for the effect of hormonal regulation unlike the unilateral pregnant model that provides an internal control separating hormonal effects from mechanical influences. Using unilaterally pregnant rats, reported that at mid-gestation protein:DNA ratio, a biochemical marker of hypertrophy, was dramatically increased in the gravid horn (subjected to stretch by growing fetus), while remaining unchanged in the nongravid horn. These studies confirm that mechanical stretch plays an important and, perhaps, dominant role in promoting the growth of the uterus during pregnancy. We studied protein:DNA ratios in pregnant rat myometrium throughout gestation and showed a marked increase in cell size during the second half of gestation, when fetal growth is maximal (Shynlova et al. 2006 ). This result indirectly indicated that mechanical stretch exerted by the growing fetus might be one of the main signals that cause the uterine myocytes to shift from the proliferative to the synthetic phase of myometrial growth. However, the ratio is an indirect method and there are currently no real numerical measurements of uterine cell volumes throughout gestation to more accurately portray the degree of growth in the myometrial SMCs. In the context of the uterus, this measurement may underestimate the true degree of myometrial hypertrophy, as polyploidal nuclei appear in the myometrium during pregnancy (van der Heijden & James 1975) . This is especially true for further study of physiological mechanisms originating and regulating myometrial hypertrophy, which require a more reliable and direct measure of cell volumes. The elucidation of the numerical measurement of cell growth will also provide a better context to test the validity of previously proposed mechanisms.
Thus, the goal of the present study was 1) to apply stereological methodology to elucidate a direct measurement of uterine SMCs volume throughout gestation and 2) to assess the contribution of mechanical signal to the maintenance of the synthetic myometrial phenotype. Firstly, using a computerized stereological approach, we elucidated statistical proof for the existence of myometrial hypertrophy during normal bilateral pregnancy. The methodology applied in this research is three-dimensional statistical analysis software, the Stereoinvestigator (MicroBrightField, Inc., Williston, VT, USA), which can calculate cell volumes by using the point sample intercept (PSI) microscope probe. In order to use the Stereoinvestigator, the membranes of individual myocytes must be clearly visible to mark the cell boundaries for the diameter measurements and consequent volume calculations to be done. Therefore, we applied anticaveolin (CAV)1 and 3 antibodies to visualize plasma membrane of individual SMCs. Secondly, to assess our hypothesis that restriction of myocyte hypertrophy to the gravid horn is due to myometrial stretch of the uterine wall by growing fetus(es), we used the unilateral pregnant rat model. The isotropic uniform random (IUR) sampling was used for tissue collection (see Material and Methods). The resulting cell diameter measurements collected allow average cell volumes to be calculated for NP, early, mid, late, term pregnant, and post partum (PP) uterine samples showing statistically reliable data and proving the occurrence of myometrial hypertrophy at late gestation.
Results

Antibody selection for immunohistochemical staining
In order to measure the size of myometrial cells using the Stereoinvestigator approach, the individual SMC boundaries must be clearly visible. CAV1, 2, and 3 are transmembrane proteins universally expressed in the small omega-shaped invaginations of plasma membrane called caveolae. CAV1 appears to be a principal protein component of caveolal membrane in vivo. It was reported recently that CAV1 was expressed at a constant level in mouse myometrium throughout gestation (Wu et al. 2008) . CAV3 represents the muscle-specific member of the CAV supergene family, as its expression is limited to striated and SMCs (Couet et al. 2001) . Therefore, anti-CAV1 and anti-CAV3 antiserum were used for immunohistochemistry analysis to find the antibody that provides the best quality immunostaining and is less susceptible to changes during the gestational period. When rat uterine tissues were immunostained with anti-CAV1 antiserum, strong positive signals were detected in plasma membranes of all SMCs in both longitudinal and circular myometrial layers ( Fig. 1 ). Analysis of CAV3 immunostaining revealed that this protein was localized to the cell membrane of all samples studied, although the staining was very weak (data not shown). Based on these results, anti-CAV1 antibodies were selected for stereological analysis of myometrial samples from bilaterally ( Fig. 1 ) and unilaterally ( Fig. 2 ) pregnant animals.
Cellular hypertrophy during normal gestation
Myometrial tissue sections from three different sample sets (nZ3 per gestational day) were stained for CAV1 protein to visualize the plasma membrane of SMCs. The stereological analysis confirmed that the dramatic increase in uterine size seen during late gestation is due to an increase in the size of individual uterine myocytes. Representative images showed little change in cell size from NP up to day 14 of pregnancy (Figs 1 and 3A) . The mean cell volumes were similar between the NP (264 G112 mm 3 ) and early pregnant uterus (day 8, 245 G90 mm 3 ). However, myometrial hypertrophy increased noticeably with gestation. From day 14 to day 19, a significant increase in SMCs size occurred (448G225 vs 771G402 mm 3 , P!0.05), uterine myocytes remained hypertrophic until term (day 22, 716G364 mm 3 ) and then dramatically decreased by 4 days PP (4PP; 296 G101 mm 3 ; Figs 1 and 3A). There was no difference between the size of myometrial cells on day 19 and day 22, confirming our earlier observations that uterine growth stabilizes at term.
Effect of biological stretch on myometrial hypertrophy
Hypertrophic changes in the myometrium were determined by measuring the volume of individual SMCs at four different gestational time points in both gravid and nongravid uterine horns. Mean cell volume increased dramatically with gestation in the gravid horn only, while no change in cellular volume was observed in the nongravid horn (Figs 2 and 3B). Myometrial hypertrophy was significantly higher in gravid uterine horn compared with the empty horn of unilaterally pregnant animals at late gestation (day 19, 1023 vs 351 mm 3 , P!0.05) and at term (day 22, mean cell volume 1114 vs 361 mm 3 , P!0.05), indicating the effect of uterine occupancy. The restriction of hypertrophy to cells within the gravid horn suggests that it is a response to the passive biological mechanical stretch of uterine walls by the growing fetus(es) as both horns develop in the same hormonal environment.
Discussion
In the present study, we tested the hypothesis that the increase in myometrial growth seen during late pregnancy is due to SMC hypertrophy caused by mechanical stretch of uterine tissue by growing fetus(es). Using stereological analysis of uterine tissue sections, we 1) provide direct measurements of individual SMC size throughout gestation and 2) demonstrate that myometrial hypertrophy occurred only in the gravid horn of unilaterally pregnant rats.
Over the last 30 years, the protein:DNA ratio was a commonly used marker to identify cellular hypertrophy in different tissues (Johansson 1984) . This widely accepted method is an indirect biochemical representation of the increase in cellular size by changes in protein content relative to the change in DNA content. Csapo et al. (1965) used this methodology to estimate The diameter of individual myometrial cells increases only in the gravid horn of unilaterally pregnant rats. Uterine tissues were collected from empty and gravid horns of unilaterally pregnant rats on different gestational days, including day 8, day 14, day 19, and day 22. Tissues were labelled with anti-caveolin-1 antibody and light microscopy images of cross sections were collected. Caveolin-1 was localized strongly within the plasma membrane of individual SMCs in the gravid uterine horn and showed a weaker staining in the empty horn. Magnification is 400!; scale bar, 50 mm. the extent of myometrial growth in uterine horn of ovariectomized rabbits inflated with a saline-filled balloon (Csapo et al. 1965) . Later an increase in protein:DNA ratio was demonstrated in NP uterine horn stretched by a saline-filled balloon indicating the induction of hypertrophy ). The injected fluid, however, does not fully imitate the shape of the growing fetus and the dynamic of the gestational process. Using unilaterally pregnant rats, showed that stretched gravid horns promoted uterine hypertrophy on day 14 and 16 of gestation, while nongravid horns of these rats experienced no growth. Interestingly, the region of the uterus immediately surrounding the enlarging fetus and, consequently, experiencing the most significant degree of stretch demonstrated greater cellular hypertrophy (protein:DNA ratio) compared with regions in between fetuses that were subjected to less mechanical stretch ). However, the appearance of polyploidal nuclei in the myometrium during pregnancy (van der Heijden & James 1975) makes the measurement of DNA content a somewhat unreliable indicator of cellular hypertrophy. The presence of polyploidal nuclei would result in a smaller protein:DNA ratio and may underestimate the true degree of myometrial hypertrophy during gestation. Until now, however, no numerical measurements of uterine cell volume were recorded to accurately describe gestational changes of the myometrial SMCs. The alternative method for the study of myometrial hypertrophy is stereological analysis, which allows direct measurement of individual cell diameters using histological sections of uterus collected during different phases of gestation. Based on the individual cell diameter, myometrial cell volumes are calculated automatically by the computer using three-dimensional statistical analysis software, Stereoinvestigator. The randomized procedure of tissue sampling allows many different intercept measurements of the cells to be collected, yielding an unbiased average cell volume for each gestational day studied. Myometrial hypertrophy was low at the beginning of pregnancy, increasing dramatically with gestational age and was partially reversed after 4PP (Figs 1 and 3 ). In accordance with our previous results, we recorded a statistically significant threefold increase in myometrial cell volume at late gestation as compared with NP samples. Although we and other investigators have shown earlier hypertrophic changes of uterine myocytes, this study is the first to directly measure the volume of myometrial SMCs throughout pregnancy. Importantly, this hypertrophic growth was only present in the gravid horn and not the empty horn of unilaterally pregnant rats, suggesting that passive biological mechanical stretch due to fetal growth may be the signal for hypertrophy. Importantly, mechanical forces were shown to be essential to stimulate hypertrophy of vascular, interstitial, and urinary bladder SMCs and cardiac myocytes. Chronic outflow obstruction of rat and mini-pig urinary bladder caused similar (2.5 fold) increase in SMC size (Lindner et al. 1988 , Nielsen et al. 1995 . Analogous to a reverse of myometrial hypertrophy during the PP involution period, removal of the obstructing ligature was followed by a partial reversal of bladder cell hypertrophy (Lindner et al. 1988 ). In addition, experimental stenosis of rat small intestine caused an up to tenfold increase in muscle volume due to an increase in both size and number of intestinal SMCs (Johansson 1984) . The experimental portal hypertension caused a hypertrophy of vascular SMCs (Johansson 1984) , accompanied by development of polyploidy in a large fraction of the cells (Owens 1989) .
We used CAV1 protein as a gestation-independent (Wu et al. 2008 ) specific marker of plasma membrane to clearly identify boundaries of individual myometrial cells. Recent studies have implicated lipid-rich membrane caveolae in mechanosensing (Rothberg et al. 1992 , Park et al. 2000 , Sunaga et al. 2004 , Bailey & Liu 2008 . Caveolae, 50-to 100-nm flask-shaped invaginations of the cell membrane, are biochemically distinct from other parts of the cell membrane as they contain large amounts of cholesterol and sphingolipids as well as CAV proteins. These maintain the shape of caveolae but also act as scaffolds for several intracellular signaling proteins (for reviews, see (Hayashi et al. 2001 , Bailey & Liu 2008 ). It is within this organelle that cells perform transmembrane trafficking and signal transduction. Caveolae are particularly abundant in muscle cells, adipocytes, fibroblasts, endothelial cells and epithelial cells. All three isoforms of CAV (CAV1, 2 and 3) are expressed in SMCs, with CAV1 being the quantitatively dominating homolog (Campbell et al. 2001 , Couet et al. 2001 . It has been reported recently that focal adhesion kinase (FAK), the major regulator of cell-ECM contacts, can up-regulate CAV1 expression in human embryonic cancer cell lines. In addition, examination of FAK C/C and FAK K/K mouse embryonic fibroblasts revealed that in cells devoid of FAK, CAV1 expression is strikingly diminished (Bailey & Liu 2008) . Macphee & Lye (2000) discovered earlier that FAK expression and activity was up-regulated in rat myometrium at late gestation. It is well known that activation of FAK causes the formation of complex specialized structures termed focal adhesions, associated with the plasma membrane of SMCs. Integrin receptors are essential components of focal adhesions. CAV1 was found in complexes with b1 integrin. CAV binds cholesterol and several signaling molecules potentially linked to integrin function, e.g. Src family kinases. It was reported that ligand-induced signaling necessary for normal b1 integrin function requires CAV (Wei et al. 1999) . We reported recently that both fibronectin and its integrin receptor a5b1 have been up-regulated at late gestation, specifically in the gravid uterine horn of unilaterally pregnant rat. We speculate now that CAV1 protein in myometrial SMCs may positively affect integrin-mediated FAK signaling.
We have shown earlier that in addition to hormones, myometrial stretch contributes to the expression of a cassette of genes (i.e. gap junctions, agonist receptors) required to activate the myometrium in order to initiate labour contraction. Although this biological stretch is exerted on the uterine wall by the growing fetus and placenta throughout pregnancy, these genes are not turned on during gestation, but instead the process occurs just before term. We speculate now that during pregnancy and prior to labour, uterine growth created by hypertrophy provides a mechanism to prevent an increase in tension on the myometrium and thus maintain uterine quiescence. The current study sheds light upon the potential mechanism regulating hypertrophic uterine growth.
Material and Methods
Animals
Wistar rats (Charles River Co., St Constance, Quebec, Canada) were housed individually under standard environmental conditions (12 h light:12 h darkness cycle) and fed Purina Rat Chow (Ralston Purina, St Louis, MO, USA) and water ad libitum. Female virgin rats were mated with male rats and day 1 of gestation was designated as the day a vaginal plug was observed. The average time of delivery was during the morning of day 23. The Samuel Lunenfeld Research Institute Animal Care Committee approved all animal experiments.
Experimental design
A. Normal pregnancy and term labor Animals were killed by carbon dioxide inhalation and uterine samples were collected on gestational days 0 (NP), 8, 14, 19, 22 , and 4PP.
B. Unilaterally pregnant rats
Under general anesthesia, virgin female rats underwent tubal ligation through a flank incision to ensure that they subsequently became pregnant in only one horn (Ou et al. 1998) . Animals were allowed to recover from surgery for at least 7 days before mating. Pregnant uterine samples from empty and gravid horns were collected on days 8, 14, 19, and 22 . For each day of gestation, tissue was collected from three different animals (nZ3).
Tissue collection
Stereological investigation required an IUR sampling method for sampling a structure in which all orientations in three dimensions have equal weight (Martin et al. 1973 , Gundersen & Jensen 1985 , Mouton 2002 . The intact uterine horns were placed in ice-cold PBS buffer and cut into 3-10 mm segments using a scalpel blade. Uterine tissue samples were collected at regular intervals from a random starting point on each uterine horn (every other pup in each gravid horn or every other uterine segment from each empty horn) and fixed immediately in 4% paraformaldehyde (PFA) solution at 4 8C for 24 h. The PFA-fixed uterine tissue segments were then gradually dehydrated in ethanol and provided further random orientation by randomly embedding all tissue segments from the same gestational day in individual paraffin blocks (Fig. 4) .
Immunohistochemistry
Tissue samples were immunostained using anti-CAV1 and anti-CAV3 antibodies to visualize plasma membrane of individual SMCs. Multiple sections of the uterine horn (5 mm thickness) were collected on Superfrost Plus slides (Fisher Scientific, Nepean, ON, Canada) depending on the randomized starting location and length of uterine horn. Paraffin sections were deparaffinized and rehydrated. Endogenous peroxidase activity was inhibited with hydrogen peroxide (5% in methanol) for 10 min, and sections were retrieved in 0.125% trypsin solution at RT for 35 min, blocked with DAKO Protein Serum-Free Blocking solution (Dako Corporation, Carpinteria, CA, USA) for 1 h and incubated overnight with goat polyclonal anti-CAV1 (1:500 for NP, d8 and d4PP and 1:1000 for d14, d19, d22; Cell Signalling Inc., Beverly, MA, USA) or mouse Stretch induces myometrial hypertrophy anti-CAV3 (1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) primary antibodies. For the negative controls, ChromPure nonspecific goat IgGs (Santa Cruz) were used at the same concentration as primary antibodies, or PBS was applied instead of the primary antibody. Secondary antibodies used were biotinylated anti-goat (1:200, Dako Corporation) and biotinylated anti-mouse (1:200; Dako). Visualization was achieved using LSAB Kits and HRP-conjugated streptavidin (DakoCytomations, Inc). Counterstaining with Harris Hematoxylin (Sigma Diagnostics) was carried out before slides were mounted with Cytoseal XYL (Richard-Allan Scientific, Kalamazoo, MI, USA). Myometrial cells from each set of tissues were observed on a Leica DMRXE microscope (Leica Microsystems, Richmond Hill, ON, Canada), and representative tissue sections were photographed with a Sony DXC-970 MD (Sony Ltd, Toronto, ON, Canada) 3CCD color video camera.
Stereological analysis
The average myometrial cell volume during gestation was estimated using a Leica DMRB microscope equipped with a DVC colour digital camera, which was connected to a Dell Precision 450 workstation and Stereoinvestigator software package (MicroBrightfield) from Wright Cell Imaging Facility in Toronto Western Hospital. The live image of each anti-CAV1-stained slide that was placed under the microscope was presented onto the workstation where the area of interest was traced and PSI probe was applied. This tool in the Stereoinvestigator generates a series of uniform random test lines, under random angle, and overlays the entire histological sample such that only individual SMCs, where marked points of test lines landed, were selected for analysis (see Fig. 4 ). Boundaries of these individual cells where intercept (line) runs through were identified and recorded using a virtual marker tool. Intercept measurements that are utilized for cell volume calculations represent intervals (in mm) between two marks. The entire area of interest was systematically scanned using the Meander Scan option. The randomized procedures allow many different intercept measurements of the cells to be collected, yielding an unbiased average cell volume for each gestational day studied (Gundersen & Jensen 1985 , Mayhew 1989 . Cell volume was calculated by the software (Stereo Investigator 7, Document Version 4.00). All measurements were made at 200!magnification and w20-40 fields of view per uterine sample were analyzed, producing a final mean volume of myocytes estimated from 250-650 cells/gestational day. The coefficient of error (CE; Gundersen & Jensen 1987) was estimated for each case. For normal pregnancy, mean CE was 0.038 (range: 0.023-0.05); for unilateral pregnancy, mean CE was 0.03846 (range: 0.027-0.05).
Statistical analysis
Individual data were expressed as meanGS.D. Gestational profiles were subjected to a one-way ANOVA followed by pairwise multiple comparison procedures (Student-Newman-Keuls method) to determine differences between groups. Data from the tubal ligation study were analyzed by two-way ANOVA followed by pairwise multiple comparison procedures. Statistical analysis was carried out using SigmaStat version 2.01 (Jandel Corp., San Rafael, CA, USA) with the level of significance for comparison set at P!0.05.
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